News

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in United Parcel Service Inc (Symbol: UPS), where a total of 16,783 contracts have traded so far, representing approximately 1.7 million underlying shares. That amounts to about 45.6% of UPS's average daily trading volume over the past month of 3.7 million shares. Particularly high volume was seen for the $136 strike call option expiring June 21, 2024, with 3,751 contracts trading so far today, representing approximately 375,100 underlying shares of UPS. Below is a chart showing UPS's trailing twelve month trading history, with the $136 strike highlighted in orange:

ImmunityBio Inc (Symbol: IBRX) options are showing a volume of 15,199 contracts thus far today. That number of contracts represents approximately 1.5 million underlying shares, working out to a sizeable 45% of IBRX's average daily trading volume over the past month, of 3.4 million shares. Particularly high volume was seen for the $7 strike call option expiring June 21, 2024, with 3,152 contracts trading so far today, representing approximately 315,200 underlying shares of IBRX. Below is a chart showing IBRX's trailing twelve month trading history, with the $7 strike highlighted in orange:

And Abbott Laboratories (Symbol: ABT) saw options trading volume of 24,896 contracts, representing approximately 2.5 million underlying shares or approximately 44.6% of ABT's average daily trading volume over the past month, of 5.6 million shares. Especially high volume was seen for the $105 strike call option expiring June 21, 2024, with 5,787 contracts trading so far today, representing approximately 578,700 underlying shares of ABT. Below is a chart showing ABT's trailing twelve month trading history, with the $105 strike highlighted in orange:

For the various different available expirations for UPS options, IBRX options, or ABT options, visit StockOptionsChannel.com.

Also see:

KOS Insider Buying
MAQC Historical Stock Prices
CVEO Videos

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.